Summary
Data from five nuclear families within a large kindred with multiple endocrine neoplasia type-2 (MEN-2) or Sipple's syndrome exclude linkage between the disease locus and the loci in the HLA complex. There were seven recombinants and seven non-recombinants in the four families with phase known data and total lod score of-2.659 for a recombination fraction of 0.1.
Similar content being viewed by others
References
Emery AEH (1976) Methodology in medical genetics: An introduction to statistical methods. Churchill Livingstone, Edinburgh London New York
Francke U, Weitkamp LR (1979) Report of the committee on the genetic constitution of chromosome 6. Birth Defects XV:32–38
Jackson CE, Conneally PM, Sizemore GW, Tashjian AH Jr (1976) Possible linear order of genes for endocrine neoplasia type 2, the P red cell antigen and HL-A on chromosome 6. Birth Defects XII: 159–164
NIAID (1979) Manual of tissue typing techniques. In: Ray JG (ed) NIH No 80-545. US Dept Health, Education and Welfare, Bethesda
Partington MW, Ghent WR, Sears EVP, Simpson NE (1981) Multiple endocrine neoplasia type II—a combined surgical and genetic approach to treatment. Can Med Assoc J 124:403–410
Simpson NE, Falk J, Forster-Gibson CJ, Goodall J, Sears E, Partington MW, Ghent W (1979) Linkage between multiple endocrine neoplasia type II (MEN II) and HLA. Birth Defects XV:204
Van Dyke DL, Jackson CE, Babu VR (1982) Localization of autosomal dominant multiple endocrine neoplasia 2 syndrome (MEN-2) to 20p12.2. Birth Defects (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simpson, N.E., Falk, J. Exclusion of linkage between the loci for multiple endocrine neoplasia type-2 (MEN-2) and HLA. Hum Genet 60, 157 (1982). https://doi.org/10.1007/BF00569703
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00569703